ABSTRACT Background: Although dietary and nutrient interventions have been extensively studied as a means of improving arterial stiffness, to our knowledge no systematic analysis of the data has been conducted. Objective: The aim of the current study was to systematically review the human clinical trial data and qualitatively examine the efficacy of dietary and nutrient interventions in the treatment of arterial stiffness. Design: We systematically searched multiple databases until July 2010 for relevant randomized controlled human clinical trials of common dietary and nutrient interventions in the treatment of arterial stiffness. Located studies were subject to strict inclusion criteria and objectively assessed for scientific quality. Results: Of the 75 relevant studies located, we considered 38 studies to be appropriate for review. Results revealed support for intakes of omega-3 (n23) fish oils (Cohen's d = 0.21-0.81) and soy isoflavones (Cohen's d = 0.35-0.39) in the treatment of arterial stiffness. There was limited but consistent evidence to suggest that salt restriction (Cohen's d = 0.28-0.37) as well as consumption of fermented-milk products (Cohen's d = 0.15-0.33) that contain bioactive peptides improved arterial stiffness. The evidentiary support for intakes of vitamins, micronutrients, and herbal medicines was insufficient. Limited but consistent evidence suggested that caffeine intake acutely increased arterial stiffness (Cohen's d = 0.34-0.51). Conclusions: Current evidence from several small studies suggests that omega-3 and soy isoflavone supplementation provides an effective means of reducing arterial stiffness. There was little research that explored intakes of herbal medicines or micronutrients in the treatment of arterial stiffness, and this remains an area of potential research.
INTRODUCTION
Vascular aging is associated with an increase in collagen, ground substance, and calcium deposition (1) that cause a progressive deterioration in vessel elasticity. Coupled with functional changes, this association leads to an increase in arterial stiffness that has detrimental effects on cardiovascular dynamics and health outcomes.
The most straightforward, valid, and reliable measure of arterial stiffness is pulse wave velocity (PWV), which is predictive of future cardiovascular events, mortality, and even dementia (2) (3) (4) . The aortic pressure is determined by the forward pressure wave created by left-ventricular contraction and the wave reflected from peripheral points (2) . An increase in central PWV advances the timing of wave reflections that arrive back at the aorta and augment the aortic systolic pressure. Central hemodynamic indexes, including the augmentation index (AIx), which reflects the aortic pressure augmentation relative to the pulse pressure, can be noninvasively measured and, as with PWV, are predictive of cardiovascular events and mortality (5) and cognitive deficits (6) . Many other noninvasive techniques have been developed to quantify arterial stiffness, including estimates of arterial compliance.
Although blood pressure (BP) is a major determinant of arterial stiffness (1) , indexes of arterial stiffness have additional predicative values over and above that of brachial BP (5) . Furthermore, vasoactive interventions can alter arterial stiffness or associated wave reflections without any observable changes in brachial BP (7) . Consequently, to establish the potential of an intervention to reduce cardiovascular risk, it is useful to quantify its effects on arterial stiffness over the rudimentary investigation of peripheral BP.
Other than structural characteristics, arterial stiffness is influenced by functional mechanisms such as vascular tone and the release of vasoactive mediators by the endothelium (8) . Although long-term healthy dietary factors may improve arterial stiffness by altering arterial structure, nutrient and dietary interventions may provide an acute means to improving arterial stiffness by targeting the functional mechanisms that regulate arterial stiffness. This may potentially include the modulation of endothelial function through increases of the bioavailability of vasoactive mediators, such as nitric oxide, as well as reduction of oxidative stress and inflammatory processes.
The concept of improving arterial stiffness with nonpharmaceutical interventions is of contemporary interest with previous reviews in this area (9, 10) . However, to our knowledge, no systematic review of the human clinical trial data has been conducted. In light of this, our review aimed to examine the current evidence regarding the efficacy of dietary and nutrient interventions to reduce arterial stiffness. We conducted a qualitative systematic review of relevant, randomized controlled clinical trials (RCTs) that investigated the effects of common dietary and nutrient interventions as a monotherapy for arterial stiffness and associated wave-reflections. We searched for trials conducted in adults without posing any further limits on the nature of the sample population.
METHODS
MEDLINE (PubMed; http://www.ncbi.nlm.nih.gov/pubmed), The Cochrane Library (http://www.thecochranelibrary.com/), and PsycINFO (http://www.apa.org/pubs/databases/psycinfo/) were searched until July 2010 by using the following terms: "arterial stiffness" OR "pulse pressure" OR "wave reflections" OR "augmentation index" OR "pulse wave velocity" OR "aortic stiffness" OR "central pressure" OR "arterial compliance" and 49 terms relating to dietary and nutrient interventions (eg, "vitamins" OR "salt" OR "caffeine" OR "polyphenols" OR "omega-3") (see supplemental Table 1 under "Supplemental data" in the online issue for a complete list of search terms and limits). Forward searching on articles that met the inclusion criteria was also performed with the Web of Science.
Located studies were subject to the following inclusion criteria: randomized and controlled; sample size of .15 subjects/ arm; use of a nonactive control; the outcome variable was a validated measure of arterial stiffness that included PWV, AIx, systemic arterial compliance (SAC), capacitive arterial compliance, or another validated measure of central arterial stiffness or central pressure; reported the effects of supplementation on resting arterial stiffness (ie, not arterial stiffness in response to exercise); used a specific dietary or nutrient intervention administered orally in the form of supplements, powder, or a beverage (nonspecific diets and enriched foods were excluded); conducted in adult humans; written in English; and had a scientific-quality index 5 out of 10 (on an augmented Jadad scale). Studies that did not meet the inclusion criteria were excluded. To ensure that appraisals were drawn from methodologically sound trials and to reduce bias at the study level, each article was rigorously analyzed for methodologic quality by using the Jadad scale (11) (see supplemental Figure 1 under "Supplemental data" in the online issue). The augmented Jadad scale was implemented because it overcomes the limitation of brevity associated with the original scale and, thus, provided a more rigorous assessment of scientific quality (12) .
With the use of the augmented Jadad scale, the quality of each study was assessed and given a score from 0 to 10, with higher scores reflecting superior quality. The systematic review process, including article searching, assessment of inclusion criteria, article quality, and data extraction was conducted by 2 researchers (MPP and NAG) with results compared and synthesized (disagreements were resolved via mutual consensus). Although a meta-analysis was beyond the scope of this review, effect sizes for each individual study were calculated. Effect sizes (Cohen's d) for each individual trial were calculated as the differences between the active intervention and placebo scores divided by the pooled baseline SD (13) . Consequently, data were extracted as the change in the respective measures of arterial stiffness in the control and active groups as well as the baseline SDs. Where SEs were reported, SDs were back calculated by using the SEs and sample sizes. When data were unavailable, authors were contacted for appropriate change scores and SDs.
RESULTS
Of the 630 initial search hits, 165 hits were for RCTs. As detailed in Figure 1 , of the 75 RCTs deemed to be relevant, 37 RCTs were eliminated because of methodologic limitations (see supplemental Table 2 under "Supplemental data" in the online issue to view excluded trials). The remaining 38 RCTs included in the review were divided into 3 groups according to the type of intervention.
Animal food-based interventions
As shown in Table 1 , 11 animal food-based interventions were included in the review, including 9 omega-3 (14-22) and 2 fermented-milk interventions (23, 24) . Of the omega-3 interventions, the average scientific-quality score was 6.6 out of 10. Aside from one acute study conducted in healthy participants, all omega-3 trials were long-term trials with supplementation periods varying from 1.5 to 25 mo. Of the chronic omega-3 trials, all but one trial reported an improvement in PWV (18, 21, 22) or capacitive arterial compliance (19, 20) as a result of omega-3 supplementation relative to that of a control, whereas a single study reported no effect of docosahexaenoic acid (DHA) on the digital volume pulse-stiffness index (16) . Effect sizes of the chronic omega-3 interventions were small to large (Cohen's d = 0.21-0.81), whereas the acute study reported no immediate reductions in PWV or the AIx after omega-3 supplementation (17) . Both fermented-milk interventions involved chronicsupplementation periods in hypertensive subjects, whereby one trial reported a significant effect on the AIx (23) , and the other trial reported a significant effect on the ambulatory arterial stiffness index (AASI) (24) . The average scientific-quality score of these 2 studies was 6 out of 10, and the effect sizes were small to moderate (Cohen's d = 0.15-0.33).
Nutrient interventions
As detailed in Table 2 , the review located 15 RCTs of sufficient methodologic rigor related to nutrient interventions. Eleven of these RCTs used vitamins, including vitamins C and E and folic acid (25-35), 3 RCTs used minerals, including salt, potassium chloride, and bicarbonate (36) (37) (38) , and one RCT used the micronutrient a-lipoic acid (39) . Samples were heterogeneous. The average quality rating of the vitamin interventions was 6.7 out of 10. Of the vitamin studies, 3 studies reported an improvement in the respective outcomes, whereas 8 studies reported no effect. Specifically, one ascorbic acid study reported a benefit on the AIx, central pressures, and reflection time (25), 2 folic acid trials reported a benefit on either SAC (29) or PWV (32), whereas 3 interventions with vitamin E, 2 interventions with vitamin C, 2 interventions with folic acid, and one intervention with combined vitamin C and E reported no effect. Only one micronutrient study was included in the review, and arterial stiffness was unchanged as a result of acute supplementation. The scientific quality of the mineral interventions was high (7.7 out of 10). Salt supplementation was shown to increase PWV in 2 studies (Cohen's d = 0.28-0.37), whereas potassium chloride and bicarbonate reduced PWV in one study.
Plant food-derived interventions
Of the 12 plant food-derived interventions detailed in Table 3 , 5 interventions involved soy or related isoflavones (40) (41) (42) (43) (44) , one intervention involved flavonoids (45), one intervention involved alcohol (46), 3 interventions involved caffeine (7, 47, 48) , one intervention involved garlic (49) , and one intervention involved conjugated linoleic acid (50) . In total, 9 studies reported an effect of treatment relative to that of a control, whereas 3 studies reported no effect. The average scientific quality index was 7.1 out of 10. Of the 5 soy or isoflavone interventions, 4 interventions showed an improvement in PWV (40, 41, 44) or SAC (41, 43) relative to that of a placebo (Cohen's d = 0.35-0.39), whereas one study reported no effect of soy intervention on wave reflections (42) . The majority of the soy interventions were conducted in samples that comprised postmenopausal women. A single study showed that consumption of black tea flavonoids reduced the digital volume pulse-stiffness index but not PWV, whereas consumption of alcoholic red wine decreased the AIx acutely relative to that for consumption of dealcoholized red wine in another study with large effects. All 3 caffeine studies reported acute increases in AIx at doses that ranged from 80 to 300 mg/d with moderate effect sizes. RCTs of high scientific quality reported no effect of intakes of garlic or conjugated linoleic acid on PWV relative to that of a placebo. With the exception of the black tea study, no clinical trials of high scientific quality investigated effects on arterial stiffness of other herbal medicines with purported cardiovascular activity (eg, Crataegus monogyna or Ginkgo biloba).
DISCUSSION
The systematic review of RCTs in the treatment of arterial stiffness revealed many dietary and nutrient interventions, which were shown to modify arterial stiffness with varying success (Tables 1-3 ). The current evidence suggested that chronic fish-oil supplementation with the long chain omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and DHA provided an efficacious means of reducing PWV and increasing arterial compliance. Although the mechanisms that underpin the effect of omega-3 on arterial stiffness remain unclear, there is substantial evidence to suggest that improvements to arterial stiffness from omega-3 are independent of BP (18, 20, 22) . The incorporation of omega-3 PUFAs into cells antagonizes omega-6-derived proinflammatory eicosanoids, which, thus, reduces inflammation, platelet aggregation, and vasoconstriction (51) , and this may explain the beneficial effects of PUFAs on arterial stiffness.
The lowest daily dosage of long-chain PUFAs that yielded an effect on arterial stiffness relative to that of a control was 540 mg EPA combined with 360 mg DHA. The largest clinical effect was also shown with this dosage. The available evidence suggested that supplementation with combined EPA and DHA had greater clinical effects on arterial stiffness (Cohen's d = 0.74-0.81) than did EPA supplementation alone (Cohen's d = 0.21-0.36), even when EPA was administered in relatively high concentrations.
Consumption of Lactobacillus helveticus fermented milk that contained the bioactive tripeptides isoleucyl-prolyl-proline and valyl-prolyl-proline was shown to be effective in reducing arterial stiffness in hypertensive patients with small to moderate effects. However, one of the 2 studies that investigated these bioactive tripeptides implemented the AASI as the primary outcome measure of arterial stiffness. Because this measure is somewhat controversial (52), further bioactive tripeptide trials are needed to confirm these preliminary findings, preferably implementing PWV as the primary outcome. Nevertheless, such reductions in AASI appear, at least in part, dependent on BP (r = 0.25, P , 0.05) (24) . Other authors have shown that fermented-milk products are antihypertensive (53) , perhaps because of the ability of these peptides to inhibit the angiotensin-converting enzyme.
A growing body of literature suggested that plant-derived interventions, such as polyphenols and related flavonoids, can improve cardiovascular health (54) . In various cultured endothelial cells, the administration of plant-derived polyphenols has been shown to enhance the production and synthesis of nitric oxide (54) . Because nitric oxide production influences large- ITT, intention-to-treat analysis; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; Ran, randomized; CS, crossover; DB, double-blind; PC, placebo-controlled; N, no; PWV, pulse wave velocity; cf-PWV, carotid-femoral PWV; AIx, augmentation index; PG, parallel groups; C1, capacitive arterial compliance; BP, blood pressure; DVP-SI, digital volume pulse stiffness index; SB, single-blind; ca-PWV, cardio-ankle PWV; LAC, large-artery compliance; ba-PWV, brachial-ankle PWV; Y, yes; Tr, reflection time; AASI, ambulatory arterial stiffness index; Ile-Pro-Pro, isoleucyl-prolyl-proline; Val-Pro-Pro, valylprolyl-proline.
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Only those arms relevant to the current review are presented. ITT, intention-to-treat analysis; Ran, randomized; PG, parallel groups; DB, double-blind; PC, placebo-controlled; N, no; AIx, augmentation index; Tr, reflection time; CSP, central systolic pressure; CDP, central diastolic pressure; PWV, pulse wave velocity; CS, crossover; cf-PWV, carotid-femoral PWV; SAC, systemic artery compliance; NA, data were not available to calculate the effect size; Y, yes; 5-MTHF, 5-methyltetrahydrofolate; bk-PWV, brachial-knee PWV; ba-PWV, brachial-ankle PWV; AC, arterial compliance estimate; AD, arterial distensibility estimate; PM, postmenopausal; PP, pulse pressure; SB, single-blind.
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TABLE 3
Plant-derived food interventions in the treatment of arterial stiffness ITT, intention-to-treat analysis; Ran, randomized; PG, parallel groups; DB, double-blind; PC, placebo-controlled; N, no; SAC, systemic artery compliance; PWV, pulse wave velocity; af-PWV, aortofemoral PWV; fd-PWV, femoro-dorsalis PWV; PM, postmenopausal; CS, crossover; AIx, augmentation index; SB, single-blind; NA, data were not available to calculate the effect size; cf-PWV, carotid-femoral PWV; DVP-SI, digital volume pulse-stiffness index; CAD, coronary artery disease; CPs, central pressures, Tr, reflection time; CSP, central systolic pressure; ar-PWV, aorta ascendens-arteria radialis PWV; Y, yes.
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artery dispensability (8) , polyphenol-based interventions that increase the bioavailability of nitric oxide may be effective in reducing arterial stiffness. Surprisingly, only one study of scientific rigor (on black tea flavonoids) investigated the efficacy of intakes of herbal medicines or teas to reduce the stiffness of central arteries with promising results. Because caffeine acutely increases arterial stiffness, the beneficial effects of tea consumption on arterial stiffness most likely stem from the high polyphenol content of tea. However, overall, support for other plant-derived interventions in the management of arterial stiffness cannot currently be extended because of an absence of welldesigned RCTs. Clinical evidence consistently revealed that caffeine has detrimental acute effects on arterial stiffness at doses ranging from 80 to 300 mg caffeine/d in healthy subjects. This acute effect of caffeine may stem from vasoconstriction precipitated by the antagonism of adenosine coupled with the release of catecholamines (10) . Although the chronic effects of caffeine intakes on arterial stiffness were not elucidated, this finding lends to the conclusion that restricting coffee consumption may reduce arterial stiffness.
Although one trial reported no effect of intakes of soy isoflavones on wave reflections, evidence from 4 trials suggested a benefit of intakes of soy and related isoflavones on arterial stiffness measured through PWV and arterial compliance. The beneficial effect of soy intakes on arterial stiffness may partly explain why populations that consume high amounts of soy have a low incidence of heart disease (55) .
The evidence for the use of vitamins and micronutrients was lacking, and the majority of studies reported no effect of treatment relative to that of placebo intake. Consequently, there is currently insufficient evidence of high scientific quality to recommend the use of vitamins or micronutrients in the treatment of arterial stiffness. Similar conclusions have previously been reached regarding the benefits of intakes of oral antioxidants in preventing or treating hypertension (56) .
In terms of minerals, consistent evidence from 2 studies of high scientific quality suggested that salt supplementation increases arterial stiffness at doses ranging from 10 to 140 mmol NaCl/d in hypertensive subjects. In one study, salt reduction was associated with decreased pulse pressure across all ethnic groups, whereas PWV decreased in blacks in response to salt reduction (37) . The current finding, whereby salt intake appeared to be detrimental to arterial stiffening, was consistent with that of a previous review (9) . Coherent with the notion that salt restriction improves BP (57) , salt restriction appears important in the management of arterial stiffness.
A number of limitations have been noted. First, because only English-language articles were searched, it is possible that some foreign but relevant articles were not included in this review. A meta-analysis was not possible because of the heterogeneity in outcome measures coupled with, in some cases, absent data that precluded the calculation of effect sizes. Although carotidfemoral PWV is regarded as the gold standard in the assessment of arterial stiffness, there are multiple indexes available for its measurement (2) . Consequently, in a review of this nature, it is unsurprising that outcome measures were heterogeneous. Because researchers or clinicians may have reservations or preferences about certain indexes, the outcome measures of each trial were acknowledged so that each trial could be independently appraised. Because of the superior predictive validity of carotidfemoral PWV (2) , future studies in the area should endeavor to explore the effects of supplementation on this measure. This is especially warranted for future omega-3 trials because, although omega-3 intake has been shown to reduce various measures of PWV, the effect of omega-3 intake on carotid-femoral PWV remains unknown. In addition, comparisons between studies were somewhat limited by the heterogeneous nature of the sample populations and dosage sizes. Nevertheless, the fact that different doses of omega-3 PUFAs were effective in improving arterial stiffness across diverse samples increased the generalizability of this finding to the general population.
Although fish-oil and soy supplementations were shown to be effective in reducing arterial stiffness, it is unclear how these reductions in arterial stiffness affect cardiovascular risk. Future research is required to longitudinally investigate how such reductions in arterial stiffness affect future cardiovascular events. Because carotid-femoral PWV is a strong predictor of future cardiovascular events (2) , further trials in the area should endeavor to quantify the effects of supplementation on this gold standard measure.
Current evidence from a number of small trials suggested that supplementation with omega-3 PUFAs and soy isoflavones offers a scientifically supported means of reducing arterial stiffness. Consistent evidence from 2 studies of high methodologic quality suggested that salt restriction is important in the management of arterial stiffness. Similarly, consistent but preliminary evidence from 2 studies also suggested that the consumption of fermented-milk products that contained bioactive peptides decreases arterial stiffness. There is insufficient evidence to recommend the use of vitamins in the management of arterial stiffness. Although the chronic effects of caffeine were not elucidated, consistent evidence suggested that caffeine intake acutely increases arterial stiffness. There was limited research that explored the use of herbal medicines or micronutrients in arterial stiffness, and this remains an area of potential research.
